Gastric Cancer Drugs Market Report 2026
Download Free Sample Buy Now
Gastric Cancer Drugs Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Gastric Cancer Drugs Market Report 2026

Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastric Cancer Drugs Market Overview

• Gastric Cancer Drugs market size has reached to $4.9 billion in 2025

• Expected to grow to $8.14 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Growing Global Aging Population And Its Impact On The Gastric Cancer Drug Market

• Market Trend: Advancements In Gastric Cancer Treatments With CLDN18.2-Targeted Therapies

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Gastric Cancer Drugs Market?

Gastric cancer drugs refer to anti-cancer medications that are taken orally as pills or are injected into a vein (via an IV line or central venous catheter). This treatment is effective for cancer that has spread to organs other than those where it originated since these medications penetrate the bloodstream and reach every part of the body.

The main types of gastric cancer drugs are doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab. Sunitinib is a chemotherapeutic agent and receptor tyrosine kinase inhibitor used to treat renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). The drugs are administered orally and parenterally and are used by hospitals, clinics, and others.

Gastric Cancer Drugs Market Global Report 2026 Market Report bar graph

What Is The Gastric Cancer Drugs Market Size and Share 2026?

The gastric cancer drugs market size has grown strongly in recent years. It will grow from $4.9 billion in 2025 to $5.39 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of gastric cancer, limited awareness of early detection, reliance on conventional chemotherapy, increasing adoption of hospital-based treatment, high cost of branded drugs.

What Is The Gastric Cancer Drugs Market Growth Forecast?

The gastric cancer drugs market size is expected to see rapid growth in the next few years. It will grow to $8.14 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to advancements in targeted therapies, growth in immunotherapy adoption, expansion of precision medicine, development of oral and injectable formulations, increasing government and private funding for cancer research. Major trends in the forecast period include personalized gastric cancer therapies, development of targeted drug delivery systems, increased use of combination therapies, expansion of outpatient cancer treatment services, growth in supportive care and symptom management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastric Cancer Drugs Market Segmentation

1) By Type: Imatinib, Trastuzumab, Other Types

2) By Route of Administration: Oral, Parenteral

3) By End User: Hospitals, Clinics, Cancer Speciality Centers

Subsegments:

1) By Imatinib: Oral Formulations, Injectable Formulations, Combination Therapies

2) By Trastuzumab: Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab

3) By Other Types: Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications

What Is The Driver Of The Gastric Cancer Drugs Market?

The increasing global aging population is expected to propel the growth of the gastric cancer drug market going forward. An aging population refers to a demographic situation in which a significant proportion of a nation's or region's residents are older, typically aged 65 and above. This phenomenon occurs when there is a sustained increase in life expectancy and a decrease in birth rates, resulting in a higher proportion of elderly individuals relative to the overall population. Older patients may have limited tolerance for certain cancer treatments, such as surgery or chemotherapy. As a result, there is a need for more tailored treatment options, including drugs, to address the specific needs and tolerances of elderly patients. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population.Therefore, the gastric cancer drug industry is anticipated to experience growth in the future, driven by the growing elderly population.

Key Players In The Global Gastric Cancer Drugs Market

Major companies operating in the gastric cancer drugs market are F. Hoffmann-La Roche, Eli Lilly and Company, Jiangsu HengRui Medicine, Biocon, Sanofi, PV Pharma Healthca

Global Gastric Cancer Drugs Market Trends and Insights

Many companies operating in the gastric cancer drugs market are focused on developing innovative products, such as CLDN18.2-targeted treatments, to improve the efficacy of therapies and provide more personalized options for patients. CLDN18.2-targeted treatment refers to therapies designed to target claudin 18.2 (CLDN18.2), a protein that is primarily expressed in certain epithelial tissues, including the gastric epithelium. For instance, in October 2024, Astellas Pharma Inc., a Japan-based company received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health for VYLOY (zolbetuximab). VYLOY (zolbetuximab) is the first only CLDN18.2-targeted treatment used for advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive. The treatment is administered in combination with fluoropyrimidine- and platinum-based chemotherapy regimens. It is indicated for adults with locally advanced unresectable negative gastric or gastroesophageal junction cancer adenocarcinoma.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastric Cancer Drugs Market?

In January 2023, Leap Therapeutics Inc. a US-based biotechnology company acquired Flame Biosciences, Inc. for an undisclosed amount. With this acquisition, Leap Therapeutics Inc. aims to enhance its oncology pipeline and expand its therapeutic offerings. This acquisition also allows Leap to integrate Flame's clinical-stage anti-Claudin18.2 antibody, FL-301, which is being developed for gastric and pancreatic cancers, into its portfolio. Flame Biosciences Inc. is a US-based biotechnology company that provides gastric cancer drugs.

Regional Insights

North America was the largest region in the gastric cancer drugs market in 2025. Middle East is expected to be the largest growing region in the global gastric cancer drugs market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Cancer Drugs Market?

The gastric cancer drugs market consists of sales of cyramza, docetaxel, and doxorubicin hydrochloride. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastric Cancer Drugs Market Report 2026?

The gastric cancer drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gastric Cancer Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.9 billion
Revenue Forecast In 2034 $7.35 billion
Growth Rate CAGR of 10.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Imatinib, Trastuzumab, Other Types
2) By Route of Administration: Oral, Parenteral
3) By End User: Hospitals, Clinics, Cancer Speciality Centers Subsegments: 1) By Imatinib: Oral Formulations, Injectable Formulations, Combination Therapies
2) By Trastuzumab: Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab
3) By Other Types: Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche, Eli Lilly and Company, Otsuka Pharmaceutical, Jiangsu HengRui Medicine, Biocon, Sanofi, PV Pharma Healthcare (India), Roche India, Novartis Oncology, Arlak Biotech (India), Healthkind labs Pvt. Ltd., SwisscheM Healthcare Pvt.Ltd, Apikos Pharma, Kolaz biotech., CStone Pharma (China), CARsgen Therapeutics (China), JW Therapeutics (China), BeiGene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Daiichi Pharmaceutical and Sankyo (Japan), AQVIDA GmbH, AstraZeneca plc, GlaxoSmithKline plc, Veropharm, Biocad, Bristol-Myers Squibb, Celon Pharma, Celltrion Inc., Imugene Limited, Merck & Co. Inc., Pfizer Inc., Sandoz AG (A Novartis Division), Eurofarma Laboratórios S.A., TUTEUR ArgentinaPierre Fabre Group, Celnova Pharma, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Abbott Laboratories, Mylan Laboratories, Gilead Sciences, BMS, Ascedis Health
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastric Cancer Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastric Cancer Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastric Cancer Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastric Cancer Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Personalized Gastric Cancer Therapies

4.2.2 Development Of Targeted Drug Delivery Systems

4.2.3 Increased Use Of Combination Therapies

4.2.4 Expansion Of Outpatient Cancer Treatment Services

4.2.5 Growth In Supportive Care And Symptom Management

5. Gastric Cancer Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Cancer Specialty Centers

5.4 Oncology Research Institutes

5.5 Ambulatory Care Centers

6. Gastric Cancer Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastric Cancer Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastric Cancer Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastric Cancer Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastric Cancer Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastric Cancer Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastric Cancer Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastric Cancer Drugs Market Segmentation

9.1. Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imatinib, Trastuzumab, Other Types

9.2. Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.3. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Cancer Speciality Centers

9.4. Global Gastric Cancer Drugs Market, Sub-Segmentation Of Imatinib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Formulations, Injectable Formulations, Combination Therapies

9.5. Global Gastric Cancer Drugs Market, Sub-Segmentation Of Trastuzumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab

9.6. Global Gastric Cancer Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications

10. Gastric Cancer Drugs Market Regional And Country Analysis

10.1. Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastric Cancer Drugs Market

11.1. Asia-Pacific Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastric Cancer Drugs Market

12.1. China Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastric Cancer Drugs Market

13.1. India Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastric Cancer Drugs Market

14.1. Japan Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastric Cancer Drugs Market

15.1. Australia Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastric Cancer Drugs Market

16.1. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastric Cancer Drugs Market

17.1. South Korea Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastric Cancer Drugs Market

18.1. Taiwan Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastric Cancer Drugs Market

19.1. South East Asia Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastric Cancer Drugs Market

20.1. Western Europe Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastric Cancer Drugs Market

21.1. UK Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastric Cancer Drugs Market

22.1. Germany Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastric Cancer Drugs Market

23.1. France Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastric Cancer Drugs Market

24.1. Italy Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastric Cancer Drugs Market

25.1. Spain Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastric Cancer Drugs Market

26.1. Eastern Europe Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastric Cancer Drugs Market

27.1. Russia Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastric Cancer Drugs Market

28.1. North America Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastric Cancer Drugs Market

29.1. USA Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastric Cancer Drugs Market

30.1. Canada Gastric Cancer Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastric Cancer Drugs Market

31.1. South America Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastric Cancer Drugs Market

32.1. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastric Cancer Drugs Market

33.1. Middle East Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastric Cancer Drugs Market

34.1. Africa Gastric Cancer Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastric Cancer Drugs Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastric Cancer Drugs Market Regulatory and Investment Landscape

36. Gastric Cancer Drugs Market Competitive Landscape And Company Profiles

36.1. Gastric Cancer Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastric Cancer Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastric Cancer Drugs Market Company Profiles

36.3.1. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Jiangsu HengRui Medicine Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Biocon Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi Overview, Products and Services, Strategy and Financial Analysis

37. Gastric Cancer Drugs Market Other Major And Innovative Companies

PV Pharma Healthcare (India), Roche India, Novartis Oncology, Arlak Biotech (India), CStone Pharma (China), CARsgen Therapeutics (China), JW Therapeutics (China), BeiGene (China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc. (Japan), Daiichi Sankyo, AstraZeneca plc, GlaxoSmithKline plc, Biocad, Bristol-Myers Squibb

38. Global Gastric Cancer Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market

40. Gastric Cancer Drugs Market High Potential Countries, Segments and Strategies

40.1 Gastric Cancer Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastric Cancer Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastric Cancer Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastric Cancer Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastric Cancer Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastric Cancer Drugs Market, Supply Chain Analysis
  • Table 4: Global Gastric Cancer Drugs Market, Major Raw Material Providers
  • Table 5: Global Gastric Cancer Drugs Market, Major Resource Providers
  • Table 6: Global Gastric Cancer Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastric Cancer Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Gastric Cancer Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Gastric Cancer Drugs Market, Major Trends
  • Table 10: Global Gastric Cancer Drugs Market, Major End Users
  • Table 11: Global Gastric Cancer Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastric Cancer Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastric Cancer Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastric Cancer Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Imatinib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Trastuzumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Gastric Cancer Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Gastric Cancer Drugs Market - Company Scoring Matrix
  • Table 97: F. Hoffmann-La Roche Financial Performance
  • Table 98: Eli Lilly and Company Financial Performance
  • Table 99: Jiangsu HengRui Medicine Financial Performance
  • Table 100: Biocon Financial Performance
  • Table 101: Sanofi Financial Performance
  • Table 102: Global Gastric Cancer Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Gastric Cancer Drugs Market, Competitive Dashboard
  • Table 104: Global Gastric Cancer Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 107: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Gastric Cancer Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastric Cancer Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastric Cancer Drugs Market, Supply Chain Analysis
  • Figure 4: Global Gastric Cancer Drugs Market, Major Raw Material Providers
  • Figure 5: Global Gastric Cancer Drugs Market, Major Resource Providers
  • Figure 6: Global Gastric Cancer Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastric Cancer Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastric Cancer Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Gastric Cancer Drugs Market, Major Trends
  • Figure 10: Global Gastric Cancer Drugs Market, Major End Users
  • Figure 11: Global Gastric Cancer Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastric Cancer Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastric Cancer Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastric Cancer Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Imatinib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Trastuzumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastric Cancer Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Gastric Cancer Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Gastric Cancer Drugs Market - Company Scoring Matrix
  • Figure 97: F. Hoffmann-La Roche Financial Performance
  • Figure 98: Eli Lilly and Company Financial Performance
  • Figure 99: Jiangsu HengRui Medicine Financial Performance
  • Figure 100: Biocon Financial Performance
  • Figure 101: Sanofi Financial Performance
  • Figure 102: Global Gastric Cancer Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Gastric Cancer Drugs Market, Competitive Dashboard
  • Figure 104: Global Gastric Cancer Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 107: Global, Gastric Cancer Drugs Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

CAGR of 9.6% Projected for Travel Vaccines Market From 2025 to 2029

Read More About CAGR of 9.6% Projected for Travel Vaccines Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Tyrosine Kinase Inhibitors Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Tyrosine Kinase Inhibitors Market Through 2029

Latest Market Developments in Unit Dose Manufacturing Industry: Forecast 2025–2029

Read More About Latest Market Developments in Unit Dose Manufacturing Industry: Forecast 2025–2029

2025–2029 Urea Cycle Disorders Treatment Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Urea Cycle Disorders Treatment Market Outlook: Regional Trends and Growth Forecast

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs ), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung canc...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) - Market...

Veterinary Orthopedic Medicine Market Report 2026 - Global Outlook – By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Other Animal Types), By Application (...

Colorectal Cancer Drugs Market Report 2026 - Global Outlook – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1 Or PD1 Liga...

Pancreatic Cancer Drugs Market Report 2026 - Global Outlook – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Ho...

Marine Audio Global Market Report 2025 – By Product (Speaker, Subwoofer, Stereo Receiver, Amplifier), By Boat Type (Inboard, Outboard, Sterndrive, Other Boats), By Technology (Wired, Wireless), By Sales (Original Equipme...

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

Frequently Asked Questions

The Gastric Cancer Drugs Market Report 2026 market was valued at $4.9 billion in 2025, increased to $5.39 billion in 2026, and is projected to reach $8.14 billion by 2030. request a sample here

The expected CAGR for the Gastric Cancer Drugs Market Report 2026 market during the forecast period 2025–2030 is 10.9%. request a sample here

Major growth driver of the market includes: Growing Global Aging Population And Its Impact On The Gastric Cancer Drug Market in the Gastric Cancer Drugs Market Report 2026 market. For further insights on this market, request a sample here

The gastric cancer drugs market covered in this report is segmented –
1) By Type: Imatinib, Trastuzumab, Other Types
2) By Route of Administration: Oral, Parenteral
3) By End User: Hospitals, Clinics, Cancer Speciality Centers Subsegments:
1) By Imatinib: Oral Formulations, Injectable Formulations, Combination Therapies
2) By Trastuzumab: Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab
3) By Other Types: Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications request a sample here

Major trend in this market includes: Advancements In Gastric Cancer Treatments With CLDN18.2-Targeted Therapies For further insights on this market, request a sample here.

Major companies operating in the Gastric Cancer Drugs Market Report 2026 market are Major companies operating in the gastric cancer drugs market are F. Hoffmann-La Roche, Eli Lilly and Company, Jiangsu HengRui Medicine, Biocon, Sanofi, PV Pharma Health request a sample here.

North America was the largest region in the gastric cancer drugs market in 2025. Middle East is expected to be the largest growing region in the global gastric cancer drugs market share during the forecast period. The regions covered in the gastric cancer drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us